CordenPharma is a global manufacturing and development partner for pharmaceuticals and active pharmaceutical ingredients (APIs). Established in 2006, it has its headquarters in Plankstadt, Germany. The company is known for providing full-service Contract Development and Manufacturing Organization (CDMO) solutions, specializing in small molecules and peptide drugs.

Its main products and services encompass drug substance manufacturing, drug product manufacturing, and pharmaceutical development services. Additionally, CordenPharma offers regulatory support, analytical services, and specialized technologies like high potency and controlled substance manufacturing. Operating on a global scale, CordenPharma has several manufacturing facilities and development centers across the world.

Notably, it has manufacturing sites in Germany, Italy, Switzerland, France, and the United States. These facilities enable the company to serve customers worldwide and ensure a robust supply chain for its products. CordenPharma has diversified through strategic partnerships, joint ventures, and subsidiaries.

For instance, its parent company, International Chemical Investors Group (ICIG), supports its operations while enabling access to essential resources and networks. In terms of market position, CordenPharma is renowned for its quality-focused manufacturing and development services. It has positioned itself as a reliable partner for pharmaceutical companies, catering to their drug manufacturing needs.

The company is well-regarded for its compliance with stringent regulatory standards, expertise in specialized technologies, and commitment to customer satisfaction. As for major events and achievements, CordenPharma expanded its manufacturing capacity with the inauguration of a new, state-of-the-art production facility in 2019. This facility is located in Colorado, USA, and strengthens the company's foothold in North America.

Currently, CordenPharma continues to grow and expand its global operations. Its prominence in the pharmaceutical manufacturing industry is supported by its broad range of services and geographical presence. The company's commitment to innovation, quality, and customer satisfaction remains crucial to its ongoing success in the global pharmaceutical market